Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
44,015,379
-
Share change
-
+4,965,087
-
Total reported value
-
$1,001,760,689
-
Put/Call ratio
-
25%
-
Price per share
-
$22.76
-
Number of holders
-
136
-
Value change
-
+$114,829,998
-
Number of buys
-
82
-
Number of sells
-
51
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q1 2021
As of 31 Mar 2021 SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) had 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,015,379 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FRANKLIN RESOURCES INC, STATE STREET CORP, EVENTIDE ASSET MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P., First Light Asset Management, LLC, VANGUARD GROUP INC, SV Health Investors, LLC, BAILLIE GIFFORD & CO, and Samsara BioCapital, LLC.
This table shows 136 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.